Clinical Trial Update: Increased Vitamin D Reduces Pulmonary Exacerbations in CF

View source ↗

Summary

A completed clinical trial indicates that increasing vitamin D supplementation reduces pulmonary exacerbations in patients with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Vitamin D3 supplementation (Cholecalciferol)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Cystic Fibrosis | Status: COMPLETED